Executive Summary
ENVALITH secured a post-earnings interview with Ms. Junko Takagi, Head of Investor Relations. Tokyo Electron expressed confidence in achieving its full-year operating income target of JPY 593B, projecting 30%+ growth in new equipment sales in Q4 standalone against cumulative 9M operating income progress of 70.7%. The company presented a proprietary, above-consensus bullish view of 15% growth in the CY2026 WFE (wafer fab equipment) market. Share gain opportunities through new products—including cryogenic etching and bonding tools—are crystallizing, underpinned by a five-year, JPY 1.5T R&D investment program that charts a clear path for medium- to long-term earnings growth. On the capital allocation front, the board resolved a JPY 150B share buyback and referenced a potential review of the dividend policy, signaling a notably more aggressive shareholder return posture.
Message From The Company
This is a point our CEO Kawai is extremely particular about: whenever we launch a new product, we make sure it is set well above the existing profitability benchmark, and we price it to fully reflect that value. This is the cornerstone of our pricing strategy.
Key Topics Discussed In The Interview
Market Share Expansion Via New Products — The Twin Pillars Of Cryogenic Etching And Bonding
In the 3D NAND channel hole etch step—where the company previously held 0% share—a cryogenic etch tool offering 2.5x the etch rate of conventional systems will be introduced starting CY2026. On the bonding side, beyond HBM applications (with an annual revenue track record of ~JPY 30B), the addressable market is expanding into NAND bonding and, looking further ahead, backside PDN for logic. Together, these are expected to be key growth drivers for the company.
Capturing AI Semiconductor Demand And Outperforming The WFE Market
Against the backdrop of a full-scale ramp in AI-related semiconductor capex, the company projects 15% WFE market growth, comprising ~20% growth in DRAM and ~15% growth in leading-edge logic. Tokyo Electron holds 90%+ global share in coater/developers and a commanding share in interconnect etch, positioning it to outgrow the broader market.
JPY 1.5T In R&D Over Five Years With Technology Development Looking 10+ Years Ahead
R&D investment is managed across four quadrants (1–3 years, 5–10 years, 10+ years, and basic research), with spending set to rise above JPY 300B per annum. Development is underway targeting next-generation architectures including CFET, vertical channel transistors, and 3D DRAM. CEO Kawai enforces a strict policy of setting new product margins above existing benchmarks, creating a direct structural link between rising new product mix and company-wide margin expansion.
ENVALITH Perspectives
A: Q4 plans call for 30%+ QoQ growth in new equipment sales, which will drive fixed-cost leverage and deliver meaningful improvement in both margins and absolute profit. Q3 saw transient mix headwinds—lower coater/developer mix and a 10-point decline in China revenue share (from 40.3% in Q2 to 31.8% in Q3)—but Q4 assumptions conservatively hold China mix in the low-30% range. With robust order momentum since last autumn, upside optionality remains.
A: Cumulative 9M Gross Profit Margin declined ~2.3pp YoY. The primary factor was higher fixed-cost absorption from lower revenue levels, followed by increased fixed costs from proactive investments such as field service headcount expansion, and thirdly, mix deterioration from lower coater/developer and China revenue shares. That said, Q3 marked the revenue trough; Q4 should see a clear margin recovery driven by both higher revenue and improved mix. Over the medium to long term, the strategy is to expand margins through a higher new product mix rather than reliance on China.
A: GAA-related products are already contributing to revenue, and HBM4-related tools are expected to generate sales early next year. This fiscal year's JPY 290B R&D budget is allocated across four quadrants (short-term 1–3 years, mid-term 5–10 years, long-term 10+ years, and basic research), covering future technologies such as CFET, vertical channel transistors, and 3D DRAM. The company maintains its five-year, JPY 1.5T investment plan (averaging 300B+ per annum), with the highest priority on etch—a segment where market growth is expected to outpace the broader WFE market, and where the company is focused on strengthening its competitive position.
A: The company forecasts 15% growth in the CY2026 WFE market. Current inquiry levels would support 20%, but the 15% figure reflects constraints such as customer cleanroom capacity shortages. By segment: DRAM ~20% growth, logic/foundry ~15% growth, NAND flat to slightly up. CY2024 growth was NAND-led, which limited the company's share gains, but CY2026 will be driven by DRAM and leading-edge logic—a mix that maximally leverages Tokyo Electron's strengths. Combined with new product launches in cryogenic etching and bonding, market share recovery and expansion are anticipated.
A: The buyback was authorized with growth investment as the top priority, backed by confidence in cash generation capacity from the next fiscal year onward. The decision also reflects awareness of the mid-term plan's ROE improvement targets. The 50% payout ratio policy has been in place since 2015, but the board is currently deliberating whether this remains the optimal framework, and changes are entirely possible. The cadence of buybacks has also shifted from once every four years to annual execution, representing a marked increase in capital allocation flexibility.
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.

